Skip to main content
Bringing Chemistry to Medicine logo
 

Bringing Chemistry to Medicine


Video Archive

 
 

Videos by Topic 

The annual Bringing Chemistry to Medicine symposium features thought leaders at the interface of chemical and biomedical sciences and is hosted by the St. Jude Department of Chemical Biology and Therapeutics and the St. Jude Comprehensive Cancer Center.

  1. image of video title slide

    Histone Mutations and Disrupted Development in Pediatric High-Grade Glioma
    Suzanne J. Baker, PhD
    St. Jude Children's Research Hospital
    Recorded: July 22, 2021

     
    image of video title slide

    Recent Insights into Chromatin Transcription
    Patrick Cramer, PhD
    Max Planck Institute for Biophysical Chemistry
    Recorded: July 22, 2021

     
    image of video title slide

    NSD2 in Lymphoid Malignancy
    Jonathan D. Licht, MD
    University of Florida Cancer Center
    Recorded: July 22, 2021

     
    image of video title slide

    Structure and Function of Mammilian SWI/SNF Chromatin Remodeling Complexes in Human Cancer
    Cigall Kadoch, PhD
    Dana-Farber Cancer Institute
    Harvard Medical School
    Broad Institute of MIT and Harvard
    Recorded: July 22, 2021

     
    image of video title slide

    Chromatin Remodeler Mutations in Cancer: Mechanisms and Therapeutic Vulnerabilities
    Charles Roberts, MD, PhD
    St. Jude Children's Research Hospital
    Recorded Sept. 24, 2020

     
    image of video title slide

    Allosteric Antagonists of Methyl-lysine Reader Domain Interactions with DNA/RNA
    Stephen Frye, PhD
    University of North Carolina, Chapel Hill
    Recorded Sept. 24, 2020

     
    image of video title slide

    Painting Chromatin with Synthetic Protein Chemistry
    Tom Muir, PhD
    Princeton University
    Recorded Sept. 24, 2020

     
    image of video title slide

    Transcriptional Enhancers and Emergence of Form and Function During Development and Evolution
    Joanna Wysocka, PhD
    Stanford University
    Recorded Sept. 24, 2020

     
     
     
  2. image of video title slide

    Three Possible Paths to Targeting Undruggable Transcripton Factors
    William G. Kaelin Jr., MD
    Harvard Medical School, Dana-Farber Cancer Institute
    Recorded: July 22, 2021

     
    image of video title slide

    Transcriptional Networks in Tumor-Infliltrating T-cells
    Anjana Rao, PhD
    LaJolla Institute for Immunology
    Recorded: July 22, 2021

     
    image of video title slide

    Personalization of Transcriptional Therapy with Drugs Targeting Nuclear Receptors
    Mitchell A. Lazar, MD, PhD
    University of Pennsylvania
    Recorded: July 22, 2021

     
    image of video title slide

    Chemical Control of Gene Expression
    Aseem Ansari, PhD
    St. Jude Children's Research Hospital
    Recorded Sept. 24, 2020

     
    image of video title slide

    Writing the Rules for Targeting Dynamic Transcriptional Coactivators
    Anna Mapp, PhD
    University of Michigan
    Recorded Sept. 24, 2020

     
    image of video title slide

    Systematic Targeting of Transcription Factor-Coactivator Protein-Protein Interactions
    Dr. Paramjit (Bobby) Arora
    New York University
    Recorded Sept. 24, 2020

     
    image of video title slide

    Targeted Protein Degradation - A New Therapeutic Strategy
    Nathanael Gray, PhD
    Stanford University
    Recorded Sept. 24, 2020

     
    image of video title slide

    Attenuating Oncogenic Transcription with Small Molecules
    Angela Koehler, PhD
    Massachusetts Institute of Technology
    Recorded Sept. 25, 2020

     
    image of video title slide

    Chemical Transcription Modulators of Promiscuous Xenobiotic Receptors
    Taosheng Chen, PhD, PMP
    St. Jude Children's Research Hospital
    Recorded Sept. 25, 2020 

     
    image of video title slide

    Targeted Protein Degradation Platform
    Zoran Rankovic, PhD
    St. Jude Children's Research Hospital
    Recorded Sept. 25, 2020

     
    image of video title slide

    Nuclear Condensates in Gene Regulation, Disease Pathology and Drug Partitioning
    Rick Young, PhD
    Massachusetts Institute of Technology
    Recorded Sept. 24, 2020

     
     
     
  3. image of video title slide

    Using Response Surface Models to Analyze Drug Combinations
    Anang A. Shelat, PhD
    St. Jude Children's Research Hospital
    Recorded: July 23, 2021

     
    image of video title slide

    Prediction of a Protein's Free Energy Surface with Validation Using Hydrogen/Deuterium Exchange
    Tobin R. Sosnick, PhD
    University of Chicago
    Recorded: July 23, 2021

     
    image of video title slide

    Computational Enzymology: The Structure, Function and Evolution of Enzymes
    Professor Dame Janet Thornton
    European Molecular Biology Laboratory
    Recorded: July 23, 2021

     
    image of video title slide

    Variation in GPCR Signaling: Implications for Drug Discovery
    M. Madan Babu, PhD, FRSC
    St. Jude Children's Research Hospital
    Recorded: July 23, 2021

     
    image of video title slide

    Bromodomain-Selective BETi as Pediatric Anticancer Agents
    Anang Shelat, PhD
    Philip Potter, PhD
    St. Jude Children's Research Hospital
    Recorded Sept. 25, 2020

     
     
  4. image of video title slide

    Chemical Control of Gene Expression
    James E. Bradner MD
    Novartis Institutes for Biomedical Research
    Recorded: July 22, 2021

     
    image of video title slide

    Discovery and Development of GPCR Allosteric Ligands: From Concept to Clinic
    Craig W. Lindsley, PhD
    Vanderbilt University
    Recorded: July 23,  2021

     
    image of video title slide

    Design, Syntheses and Studies of New Antibiotics
    Marvin J. Miller, PhD
    University of Notre Dame
    Recorded: July 23, 2021

     
    image of video title slide

    Bridge Over Troubled Water Networks – Binding and Garfunkel
    Marcus Fischer, PhD
    St. Jude Children's Research Hospital
    Recorded Sept. 25, 2020

     
     
    image of video title slide

    History and Future of Thalidomide Analogs in Human Health
    Phil Chamberlain, PhD
    Neomorph, Inc.
    Recorded Sept. 25, 2020
     

     
     

Return to Symposium Page